ambossIconambossIcon

Acute rheumatic fever

Last updated: January 17, 2025

Summarytoggle arrow icon

Acute rheumatic fever (ARF) is an inflammatory sequela involving the heart, joints, skin, and central nervous system (CNS) that occurs two to four weeks after an untreated group A β‑hemolytic streptococcal infection (GAS). The pathogenic mechanisms that cause rheumatic fever are not completely understood, but molecular mimicry between streptococcal M protein and human cardiac myosin proteins is thought to play a role. Because of the structural similarities between the two proteins, antibodies and T cells activated to respond to streptococcal proteins also react with the human proteins, causing tissue injury and inflammation. In addition to nonspecific symptoms (e.g., fever, malaise, and fatigue), patients present with symptoms involving the heart (carditis or valvulitis), joints (migratory polyarthritis), skin (subcutaneous nodules, erythema marginatum), and/or CNS (Sydenham chorea). The diagnosis of ARF is primarily clinical and based on the Jones criteria. Diagnostic evaluation in ARF typically shows elevated inflammatory markers, positive antistreptococcal antibodies, and valvular damage on echocardiogram. Treatment of ARF includes antibiotic therapy for GAS eradication, symptom-based treatment (e.g., for arthritis), and management of associated complications, which may include progressive, permanent damage to the heart valves (especially the mitral valve), resulting in chronic rheumatic heart disease (RHD). Long-term antibiotic prophylaxis and monitoring are recommended in all patients with ARF and RHD to prevent ARF recurrence and RHD progression.

Icon of a lock

Register or log in , in order to read the full article.

Definitionstoggle arrow icon

  • Acute rheumatic fever: (ARF): delayed inflammatory complication of group A β‑hemolytic streptococcal infection; usually occurs within 1–5 weeks after the acute infection [1][2]
  • Rheumatic carditis: a manifestation of ARF that includes acute pancarditis and/or valvulitis [3]
  • Rheumatic heart disease (RHD): chronic cardiac valvular or muscle damage as a complication of ARF [1][3]
Icon of a lock

Register or log in , in order to read the full article.

Epidemiologytoggle arrow icon

  • Peak incidence: 5–15 years of age [1][3]
  • Prevalence: more common in resource-limited countries [1]

Epidemiological data refers to the US, unless otherwise specified.

Icon of a lock

Register or log in , in order to read the full article.

Etiologytoggle arrow icon

Previous infection with group A β‑hemolytic streptococcus (GAS), also referred to as Streptococcus pyogenes [1]

Icon of a lock

Register or log in , in order to read the full article.

Pathophysiologytoggle arrow icon

Icon of a lock

Register or log in , in order to read the full article.

Pathologytoggle arrow icon

Icon of a lock

Register or log in , in order to read the full article.

Clinical featurestoggle arrow icon

Features of ARF usually manifest within 1–5 weeks following a GAS infection. Sydenham chorea typically manifest later (i.e., 1–8 months after of the initial infection). [2]

Rheumatic heart disease tends to involve the high-pressure valves (i.e., the mitral and aortic valves).

Valvular lesions sometimes do not manifest until pregnancy, when blood volume is increased. [1]

The symptoms of acute rheumatic fever can be remembered by reading the JONES criteria (see “Diagnostics” below) as an acronym that replaces the “o” with a heart: J = Joints, ♥ = Pancarditis, N = Nodules, E = Erythema marginatum, S = Sydenham chorea

Icon of a lock

Register or log in , in order to read the full article.

Diagnosistoggle arrow icon

General principles [1][4][9]

In settings where testing for GAS infection is limited, consider empirical treatment of ARF in patients with suggestive clinical features even in the absence of confirmed GAS infection. [1]

Revised Jones criteria [1][2][9]

  • Diagnostic criteria for patients with laboratory findings of a preceding GAS infection
    • Initial episode of ARF: two major criteria or one major plus two minor criteria
    • Recurrent ARF: either the same as for an initial episode of ARF or the presence of three minor criteria
Revised Jones criteria for the diagnosis of ARF [1][2][9]

Low-risk populations

Moderate- to high-risk populations
Major criteria
Minor criteria

Routine laboratory studies [9][10]

Initial laboratory findings typically show nonspecific signs of infection.

Confirmation of GAS infection [9][10]

Assessment for cardiac involvement [1][3][5]

Obtain an ECG and echocardiography in all patients with confirmed or suspected ARF.

Cardiac findings in ARF and RHD [1][3][5]
Modality Characteristic findings
ECG [11]
Echocardiography [5][12]
Chest x-ray [3]

Assessment for neurological involvement [13][14]

  • The diagnosis of Sydenham chorea is based on clinical and laboratory findings.
  • Neuroimaging (MRI or CT brain)
    • Not routinely indicated but may be performed to exclude other forms of chorea
    • Findings are nonspecific and variable.
  • Lumbar puncture: not routinely indicated; may be performed to exclude other disorders
  • Echocardiography should be obtained in all patients with Sydenham chorea because concurrent cardiac involvement is common. [11]
Icon of a lock

Register or log in , in order to read the full article.

Treatmenttoggle arrow icon

Management of ARF involves antibiotics to treat acute GAS infection, supportive management for fever and/or arthritis, management of associated complications, and long-term antibiotic prophylaxis to prevent ARF recurrence and RHD progression.

GAS eradication [1][2][10][15]

The following antibiotics are recommended for the eradication of GAS after pharyngitis.

There is insufficient evidence to recommend specific antibiotics for the eradication of GAS and prevention of ARF after skin and soft tissue infections; follow standard recommendations for antibiotic therapy for soft tissue infection. [1]

Symptomatic treatment of arthritis and fever [10][11]

  • ARF not confirmed [11]
  • ARF confirmed
    • NSAIDs
    • Titrate dosage based on treatment response. [10][11]
      • Use the lowest effective dose for the shortest duration.
      • No symptomatic improvement after 2–3 days of treatment: Consider alternative diagnoses.
      • Symptoms worsen after dose reduction: Resume higher dose for a short period.
      • Total duration of treatment: 1–12 weeks [10][11]
    • In patients with arthritis, a period of activity restriction may be indicated; encourage ambulation once pain and joint tenderness improve.

Anti-inflammatory drugs relieve ARF symptoms. There is insufficient evidence to recommend their use to prevent progression to RHD. [1][10]

Icon of a lock

Register or log in , in order to read the full article.

Management of complicationstoggle arrow icon

Rheumatic heart disease

Screening for RHD [1]

Consider in populations or areas with a moderate or high risk of rheumatic heart disease. [1]

  • Modality: echocardiography
  • Recommended groups:
    • Pregnant individuals
    • Children aged 5–19 years
  • Screening frequency: not clearly defined; tailor to local protocols and available resources.

Management of RHD [3][10]

Sydenham chorea [10][11][17]

In the majority of cases, Sydenham chorea is self-limited, with most patients seeing an improvement within a few weeks and nearly all patients fully recovered by six months.

  • Supportive therapy: indicated for all patients; may be the only treatment required in mild disease
    • Rest in a calm environment
    • Avoidance of overstimulation
    • Patient and caregiver education about the condition
  • Pharmacotherapy
Icon of a lock

Register or log in , in order to read the full article.

Prevention of ARF recurrence and RHD progressiontoggle arrow icon

General principles [1][2][3]

Long-term antibiotic prophylaxis to prevent ARF recurrence is essential; ARF can recur even after an asymptomatic or appropriately treated symptomatic GAS infection. [1][2][3]

Long-term antibiotic prophylaxis [1][2][19]

  • Indication: all patients with ARF or RHD
  • Timing: immediately after completion of antibiotics for ARF
  • Agents
  • Duration: Use the longest applicable course of treatment based on patient factors. [10][19]
    • Possible ARF : 12 months [2][3][10]
    • Rheumatic fever without carditis: 5 years or until the patient reaches 21 years of age [2][3]
    • Rheumatic fever with carditis and without residual heart disease: 10 years or until the patient reaches 21 years of age
    • Rheumatic fever with carditis and permanent valvular heart defects: 10 years or until the patient reaches 40 years of age [2][3]
    • Continue antibiotic prophylaxis beyond the above durations in patients at high risk of GAS infection (e.g., frequent contact with children). [2]

Adherence to long-term antibiotic prophylaxis can be challenging. Address risk factors for poor adherence and, for patients who experience pain from injections, mix local anesthetic with the injectable solution to reduce pain. [1]

Icon of a lock

Register or log in , in order to read the full article.

Prognosistoggle arrow icon

Cardiac involvement is the most important prognostic factor.

Icon of a lock

Register or log in , in order to read the full article.

Preventiontoggle arrow icon

Icon of a lock

Register or log in , in order to read the full article.

Start your trial, and get 5 days of unlimited access to over 1,100 medical articles and 5,000 USMLE and NBME exam-style questions.
disclaimer Evidence-based content, created and peer-reviewed by physicians. Read the disclaimer